The landscape of neuropsychiatric treatment is undergoing a massive paradigm shift. For decades, conventional medicine relied heavily on daily pharmaceutical interventions designed to suppress symptoms rather than repair underlying neural tissue. However, conditions like Post-Traumatic Stress Disorder (PTSD), Attention-Deficit/Hyperactivity Disorder (ADHD), and chronic substance use disorders involve deeply entrenched neural networks that resist traditional chemical […]